3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
5
Cardiotoxicity
2
Solid Tumors
1
Prostatic Neoplasms
1
Inflammation
1
Hyperglycemia
1
Hereditary Sensory and Autonomic Neuropathies
1
Heart Failure
1
Interventions
Fulvestrant
2
Alpelisib
2
exemestane
1
dapagliflozin
1
Vildagliptin
1
Tamoxifen
1
Metformin
1
Letrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Hyperglycemia
×
dapagliflozin
×
Clear all
NCT04899349
2024-10-09
EPIK-B4
Novartis
Phase 2
Terminated
2 enrolled
8 charts